 |
HDF-LV-RTS-MMP1 (human dermal fibroblasts genetically modified with LV-RTS-MMP1) and Veledimex |
|---|---|
| Trade Name | |
| Orphan Indication | Localized scleroderma |
| USA Market Approval | USA |
| USA Designation Date | 2016-04-19 00:00:00 |
| Sponsor | Fibrocell Technologies, Inc.;405 Eagleview Blvd;Exton, Pennsylvania, 19341 |
